This study aimed to explore the effects of Huangqi-Hetao decoction (HH) on cognitive function in amyloid precursor protein/presenilin 1 transgenic (APP/PS1Tg) mice and determine its potential role in attenuating Alzheimer's disease (AD)–related pathology and elucidating the underlying mechanisms.
Methods
APP/PS1Tg mice were raised to 8 months of age and randomly assigned to the HH group or the AD group. Age-matched C57BL/6 wild-type (WT) mice served as controls. Mice in the HH group received HH daily, whereas the AD and WT groups received no treatment.
Results
Compared with the AD group, the HH group demonstrated significantly reduced hippocampal expression of Iba-1 (p < 0.01), NF-κB (p < 0.01), GFAP (p < 0.05), and p38 MAPK (p < 0.005). Malondialdehyde (MDA) levels were significantly reduced (p < 0.005), whereas NeuN expression was significantly increased (p < 0.01). In the Morris water maze, mice treated with HH exhibited shorter total swimming distance and escape latency (p < 0.001), shorter time to first reach the target quadrant (p < 0.05), reduced average distance to the platform (p < 0.01), and shorter time from entry to the platform (p < 0.001) compared with the AD group.
Conclusion
HH improved cognitive function in APP/PS1 mice. The underlying mechanisms may involve suppression of NF-κB overactivation, inhibition of astrocytic and microglial activation, downregulation of p38 MAPK signaling, reduction of oxidative stress, and MDA accumulation, leading to attenuation of hippocampal pathological changes.
CuiH.CuiH.CuiD., et al. (2017). Clinical observation on 86 patients with vascular dementia treated with Qingxin lotus seed decoction in traditional Korean medicine. Lishizhen Medicine and Materia Medica Research, 28(06), 1383–1384. https://doi.org/10.3969/j.issn.1008-0805.2017.06.036
2.
EdricW.JennyL.BMJ., et al. (2024). Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort. Immunity & Ageing, 21(1), 36–36. https://doi.org/10.1186/s12979-024-00443-2
3.
HermidaA. P.PetridesG.LapidM., et al. (2020). Treatment parameters and rationale for the use of electroconvulsive therapy for the management of treatment-refractory agitation in Alzheimer's disease. The American Journal of Geriatric Psychiatry, 28(4), S144–S145. https://doi.org/10.1016/j.jagp.2020.01.177
4.
HongJ.BaiB.BenY. (2020). Study on the in vitro antioxidant activity of total polyphenols from adzuki beans. Guangdong Chemical Industry. Guangdong Chemical, 47(15), 280–281. https://doi.org/10.3969/j.issn.1007-1865.2020.15.135
5.
HouM.YangL. (2025). Trends and forecasts of the prevalence and mortality of Alzheimer's disease and other dementias in China. Frontiers in Public Health, 13, 1616232. https://doi.org/10.3389/fpubh.2025.1616232
6.
HuC.XianglongM.ChenxuN., et al. (2020). Research progress of yam and its network pharmacological analysis for anti-aging. World science & technology - modernization of traditional Chinese medicine. World Science and Technology-Modernization of Traditional Chinese Medicine and Materia Medica, 22(07), 2348–2365. https://doi.org/10.11842/wst.20190722007
7.
HuN. N.ZhangX. J. (2021). Research progress on chemical constituents and pharmacological effects of Astragalus membranaceus. Information on Traditional Chinese Medicine, 38(1), 76–82. https://doi.org/10.19656/j.cnki.1002-2406.210118．
8.
JianZ.JianD.LinW., et al. (2022). Effects of acupuncture plus medication on hippocampus SIRT1 and FOXO3a expression, MDA content, and SOD activity of rats with Alzheimer disease. Journal of Acupuncture and Tuina Science, 20(5), 329–338. https://doi.org/10.1007/s11726-022-1335-3
9.
KaurD.GrewalK. A.AlmasoudiH. S., et al. (2025). Neuroprotective effect of tozasertib in streptozotocin-induced Alzheimer’s mice model. Scientific Reports, 15(1), 28963–28963. https://doi.org/10.1038/s41598-025-13920-5
10.
KeikoH.YuhkiS.HarukaS., et al. (2023). Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Neurobiology of Aging, 123, 63–74. https://doi.org/10.1016/j.neurobiolaging.2022.12.003
11.
LinP.WangJ.LiY., et al. (2024). LINC00472 regulates ferroptosis of neurons in Alzheimer’s disease via FOXO1. Dementia and Geriatric Cognitive Disorders, 53(3), 107–118. https://doi.org/10.1159/000537883
12.
LiuP.ZhouY.ShiJ., et al. (2023). Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway. Phytomedicine, 115, 154801–154801. https://doi.org/10.1016/j.phymed.2023.154801
13.
LiuY. (2023). Research on the protective effect and mechanism of Polygonatum sibiricum polysaccharides on cognitive function impairment induced by chronic stress. Hunan University of Chinese Medicine. https://doi.org/10.27138/d.cnki.ghuzc.2023.000224
14.
LuJ.WuK.ShaX., et al. (2024). TRPV1 Alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease. Translational Neurodegeneration, 13(1), 52. https://doi.org/10.1186/s40035-024-00445-6
15.
MaruyamaH.GomiM.LwinT. T.YoneyamaA.SasakiT. (2024). [18f]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique. Annals of Nuclear Medicine, 38(2), 120–130. https://doi.org/10.1007/s12149-023-01879-0
16.
MNE.RossA.ZuzanaN., et al. (2021). The association between homocysteine and memory in older adults. Journal of Alzheimer's Disease, 81(1), 413–426. https://doi.org/10.3233/JAD-201558
17.
NatarajanC.Phu-CuongP.BernadetteT., et al. (2022). Functional role of PLD1 signalosome in tauopathies. Alzheimer's & Dementia, 18(S3), e67704. https://doi.org/10.1002/alz.067704
18.
PengT.ZhangH.YangY., et al. (2024). Research progress on the pharmacological mechanism of Astragalus in the treatment of vascular dementia. China Medicine, 19(02), 297–302. https://doi.org/10.3760/j.issn.1673-4777.2024.02.032
19.
PizarroE. B.GarcíaD. M.MartinA. G., et al. (2024). Utility of plasma GFAP as a biomarker for Alzheimer's disease using chemiluminescent microparticle immunoassay. Alzheimer's & Dementia, 20(S2), e091165. https://doi.org/10.1002/alz.091165
20.
SelkoeD. J.HardyJ. (2016). The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Molecular Medicine, 8(6), 595–608. https://doi.org/10.15252/emmm.201606210
21.
SinghK. M.FuM.HanS., et al. (2025). Chaperone-mediated responses and mitochondrial–endoplasmic reticulum coupling: Emerging insight into Alzheimer’s disease. Cells, 14(15), 1179–1179. https://doi.org/10.3390/cells14151179
22.
van DyckC.-H.SwansonC.-J.AisenP., et al. (2023). Lecanemab in early Alzheimer's disease. The New England Journal of Medicine, 388(1), 9–21. https://doi.org/10.1056/NEJMoa2212948
23.
XueY. Y.ZhangS. Z.LinR. R., et al. (2024). CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation. Translational Neurodegeneration, 13(1), 64. https://doi.org/10.1186/s40035-024-00454-5
24.
YangS.CuiR. T.LiuY. L. (2016). Research progress of cytological and molecular mechanism on vascular dementia. Chinese Journal of Clinicians (Electronic Edition), 10(12), 1785–1789. https://doi.org/10.3877/cma.j.issn.1674-0785.2016.12.027
25.
YuD. T.LiR. X.SunJ. R., et al. (2025). Global mortality, prevalence and disability-adjusted life years of Alzheimer’s disease and other dementias in adults aged 60 years or older, and the impact of the COVID-19 pandemic: A comprehensive analysis for the global burden of disease 2021. BMC Psychiatry, 25(1), 503. https://doi.org/10.1186/s12888-025-06661-2
26.
YuR.MichaelianJ. C.KongS. D., et al. (2024). Associations of C-reactive protein and homocysteine with neuropsychological outcomes in older adults at risk of dementia. Alzheimer's & Dementia, 20(S2), e083882. https://doi.org/10.1002/alz.083882
27.
ZhaX.LiuX.WeiM., et al. (2025). Microbiota-derived lysophosphatidylcholine alleviates Alzheimer’s disease pathology via suppressing ferroptosis. Cell Metabolism, 37(1), 169–186. e9. https://doi.org/10.1016/j.cmet.2024.10.006
28.
ZhouL.ZhuS.WangL. (2011). Effects of walnut kernel extract on Ach, ChAT and AchE activities in senile dementia model rats. Chinese Journal of Hospital Pharmacy, 31(06), 446–449. https://doi.org/10.3969/j.issn.1673-0143.2011.06.024
